Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cotranslational Protein Translocation01:20

Cotranslational Protein Translocation

9.4K
Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
9.4K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

673
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
673
Transport Across the Golgi01:26

Transport Across the Golgi

5.8K
While it is unclear how molecules move between adjacent Golgi cisternae, it is apparent that the molecules move from cis- cisterna, the entry face, to the trans- cisterna, the exit face. Experiments initially suggested vesicles that bud from one cisterna and fuse with the next cisterna to transport proteins between the cisternae. This vesicular transport model describes the Golgi apparatus as a relatively static structure with a unique enzyme composition in each cisterna. Molecules are...
5.8K
Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

3.0K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
3.0K
Introduction to Membrane Traffic01:44

Introduction to Membrane Traffic

9.1K
The ER, Golgi apparatus, endosomes, and lysosomes work in tandem to modify, sort, and package proteins and lipids. An integrated membrane trafficking network facilitates the back and forth shuttling of molecules within different organelles in the same cell or across the cell membrane.
The transport of soluble and membrane proteins is mediated by transport vesicles that collect cargo from one cellular compartment and deliver it to another by fusing with the target organelle membrane. The Rab...
9.1K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

952
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
952

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vanzacaftor-Tezacaftor as an alternative therapeutic resource for the ETI-Resistant L467F-F508del Allele: Ex vivo prediction and exploratory clinical assessment.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

ECFS statement on theratyping and theranostics in the context of rare and ultrarare CFTR variants in people with CF.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Investigation of HE4 expression concerning epithelial-mesenchymal transition (EMT) in cystic fibrosis epithelial cells.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Targeting PI3Kγ anchoring enhances CFTR membrane localization and modulator efficacy via PKD1.

JCI insight·2026
Same author

Author's Reply to Yang and Wang: "Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models".

Molecular diagnosis & therapy·2026
Same author

RFFL antisense oligonucleotides: A novel stabilization strategy to broaden the reach of CFTR modulator therapy.

Molecular therapy. Nucleic acids·2026
Same journal

Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver disease.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Healthcare priorities and needs for LGBTQIA+ people with cystic fibrosis: A concept mapping study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Persistence of large P. aeruginosa aggregates despite reduced airway burden in people with cystic fibrosis on CFTR modulator therapy.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same journal

Partnership between cystic fibrosis centres in Europe: The Twinning Project.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

14.9K

CFTR processing, trafficking and interactions.

Margarida D Amaral1, Darren M Hutt2, Valeria Tomati3

  • 1University of Lisboa, Faculty of Sciences, BioISI-Biosystems & Integrative Sciences Institute, Portugal.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|November 5, 2019
PubMed
Summary
This summary is machine-generated.

Cystic fibrosis (CF) mutations impact CFTR protein function. Targeting the CFTR Functional Landscape and interacting proteins offers a promising strategy to correct defects in CFTR, improving outcomes for individuals with CF.

Keywords:
CFTR Cl-channelCFTR correctorsCFTR functional landscapeCFTR interactomeF508del-CFTRProteostasis regulatorssiRNA screening

More Related Videos

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes
10:05

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes

Published on: August 13, 2012

11.7K
Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
09:59

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Published on: March 9, 2015

12.6K

Related Experiment Videos

Last Updated: Jan 4, 2026

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

14.9K
In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes
10:05

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes

Published on: August 13, 2012

11.7K
Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
09:59

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Published on: March 9, 2015

12.6K

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Cystic Fibrosis (CF) is linked to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
  • The common F508del mutation impairs CFTR processing, stability, and chloride channel function.
  • CFTR function is modulated by a network of interacting proteins, termed the CFTR Functional Landscape.

Purpose of the Study:

  • To review recent research on genetic variations affecting CFTR-proteostasis interactions.
  • To overview strategies for modulating the CFTR protein network to correct F508del-associated defects.
  • To identify novel therapeutic targets within the CFTR network for synergistic CFTR correction.

Main Methods:

  • Functional genomics approaches to manipulate CFTR interacting proteins.
  • Analysis of genetic variation impacts on CFTR polypeptide interactions with the proteostatic environment.
  • Review of studies modulating specific components of the CFTR protein network.

Main Results:

  • Genetic variations influence how nascent CFTR interacts with the proteostatic environment.
  • Modulation of specific CFTR network components can rescue trafficking and function defects.
  • Identification of key proteins involved in CFTR processing is ongoing.

Conclusions:

  • The CFTR Functional Landscape presents viable targets for therapeutic intervention in CF.
  • Modulating protein interactions offers a strategy to correct CFTR defects caused by mutations like F508del.
  • Novel therapeutic targets could lead to synergistic correction of mutant CFTR, benefiting CF patients.